Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human TRPC4 Stable Cell Line

    [CAT#: S01YF-1123-KX56]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Ion Channel Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    TRPC4
    Target Family
    TRPC
    Target Protein Species
    Human
    Host Cell Type
    U266; MM.1s; HS-5; CHO-K1; HEK293
    Target Classification
    Ion Channel Cell Lines
    Target Research Area
    CNS Research; Pain and Addiction Research
    Related Diseases
    Oculoectodermal Syndrome; Mutilating Palmoplantar Keratoderma
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Whether TRPC4 serves as a SOC or ROC is a matter of debate. It has been proposed that AA activates TRPC4 to generate a ROC. Specifically, by employing siRNA and antisense tactics to decrease endogenous TRPC4 expression, it was demonstrated that TRPC4 is necessary for both receptor-operated and OAG-induced Ca2+ entry as well as AA-induced Ca2+ oscillations, but not for SOC function. Since AA has been found to activate a number of MS channels in the absence of applied stretch, where it appears to work by directly modifying the mechanical properties of the bilayer surrounding the channel, this activation of AA may have consequences for the mechanosensitivity of TRPC4. The customized TRPC4 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Amy

    The web-page is easy to navigate in order to choose or customize the product. Feb 12 2020

    chat Verified Customer

    chat Sharon

    The Human TRPC4 Stable Cell Line is perfect for my research. Jan 05 2021

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 TRPC4 channel contributes to MTI-101 induced Ca2+/Na+ influx and cell death.

    Relative expression levels of TRPC1, TRPC4, and TRPC5 mRNA in U266, MM.1s, and HS-5 cell lines. In each cell line, the amount of expression of the corresponding mRNA is displayed in relation to GAPDH.

    Ref: Elzamzamy, Osama M., et al. "Transient receptor potential C 1/4/5 is a determinant of MTI-101 induced calcium influx and cell death in multiple myeloma." Cells 10.6 (2021): 1490.

    Pubmed: 34199280

    DOI: 10.3390/cells10061490

    Research Highlights

    Novel pharmacological targets and techniques are highly sought for, as current medicines for common cancer types, such as renal cell cancer, are frequently unspecific and unsuccessful.
    Akbulut, Yasemin, et al. "(−)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels." Angewandte Chemie International Edition 54.12 (2015): 3787-3791.
    Pubmed: 25707820   DOI: 10.1002/anie.201411511

    Gaining more understanding of the molecular underpinnings of TRPC channel activation can be facilitated by identifying the regulatory role of the NHERF proteins in the TRPC4/5-NHERF protein complex. Subsequent investigations must elucidate the physiological and pathological roles of this multi-protein channel complex.
    Mederos y Schnitzler, Michael, Thomas Gudermann, and Ursula Storch. "Emerging roles of diacylglycerol-sensitive TRPC4/5 channels." Cells 7.11 (2018): 218.
    Pubmed: 30463370   DOI: 10.3390/cells7110218

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare